U.S. market Closed. Opens in 2 days 2 hours 47 minutes

AVTX | Avalo Therapeutics, Inc. Stock Financials Income Statements Annual

(Stock Exchange: NASDAQ)
*Sign In to persist settings
Financial Year End2023-12-312022-12-312021-12-312020-12-312019-12-312018-12-312017-12-312016-12-312015-12-312014-12-312013-12-31
Revenue1.92M18.05M5.40M6.70M6.75M18.33M27.81M1.15MN/AN/AN/A
Cost of Revenue1.28M3.43M1.49M300.00K11.63M7.48M635.65KN/AN/AN/AN/A
Gross Profit640.00K14.62M3.91M6.40M-4.88M10.85M27.18MN/AN/AN/AN/A
Operating Expenses24.08M52.06M86.04M53.69M24.71M29.52M13.29M17.23M11.01M17.12M12.93M
Selling, General & Admin10.30M20.71M24.66M19.76M11.61M19.20M8.91M7.08M4.42M4.88M4.02M
Research & Development13.78M31.31M59.84M32.19M11.76M5.79M4.37M10.15M6.59M12.24M8.91M
Other Operating Expenses-42.00K38.00K1.55M1.74M1.34M13.66KN/AN/AN/AN/AN/A
Operating Income-23.44M-37.44M-82.13M-26.95M-17.39M-39.31M13.89M-16.08M-11.01M-17.12M-12.93M
Other Expenses / Income-8.09M-4.19M-2.41M-40.22M1.40M-20.61M-53.64K-391.56K519.84K1.06M-110.56K
Before Tax Income-31.53M-41.63M-84.55M-67.18M-15.99M-40.09M13.84M-16.47M-10.49M-16.06M-13.05M
Income Tax Expenses14.00K28.00K-196.00K-2.79M280.00K-33.91K1.97MN/AN/AN/AN/A
Net Income-31.54M-41.66M-84.35M-64.38M-16.27M-40.05M11.87M-16.47M-10.49M-16.06M-13.05M
Interest Expenses3.42M4.17M-2.39MN/AN/A-811.62K-24.02KN/AN/AN/AN/A
Basic Shares Outstanding277.73K39.20K36.19K25.51K19.85K2.90M1.53M8.83M2.23M3.50M4.63M
Diluted Shares Outstanding277.73K39.20K36.19K25.51K19.85K2.90M1.56M8.83M2.23M3.50M4.63M
EBITDA-23.29M-37.42M-80.59M-25.21M-17.36M6.50M14.24M-16.44M-12.30M-19.35M-12.79M
EBITDA Margin-1,210.29%-207.31%-1,492.89%-376.35%-257.20%35.49%51.19%-1,426.27%0.00%0.00%0.00%
EBIT-28.11M-37.46M-86.94M-67.18M-15.99M-40.90M13.81M-16.47M-10.49M-16.06M-13.05M
EBIT Margin-1,461.17%-207.52%-1,610.52%-1,002.79%-236.90%-223.16%49.66%-1,428.60%0.00%0.00%0.00%
Financial Year End2023-12-312022-12-312021-12-312020-12-312019-12-312018-12-312017-12-312016-12-312015-12-312014-12-312013-12-31
An error has occurred. This application may no longer respond until reloaded. Reload 🗙